[Development of a vaccine against solid tumors. Reinjection of genetically modified, IL 2 and interferon producing tumor cells].
Obst
G
G
Klinik für Innere Medizin, Kreiskrankenhaus Burgwedel.
D000818:Animals; D002461:Cell Line, Transformed; D006801:Humans; D016233:Immunotherapy, Active / Q000379:methods*; D007371:Interferon-gamma / Q000235:genetics* / Q000276:immunology; D007376:Interleukin-2 / Q000235:genetics* / Q000276:immunology; D051379:Mice; D008807:Mice, Inbred BALB C; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D010865:Pilot Projects; D014407:Tumor Cells, Cultured / Q000276:immunology / Q000637:transplantation*; D014614:Vaccines, Synthetic / Q000276:immunology*
D007376:Interleukin-2; D014614:Vaccines, Synthetic; D007371:Interferon-gamma
Entwicklung einer Impfung gegen solide Tumoren. Reinjektion genetisch veränderter, IL-2 und Interferon produzierender Tumorzellen.